Tenaya Therapeutics, Inc.
Ticker: 1858848
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY26 |
|---|---|---|
| INCOME | ||
| Revenue | 1.11+382.6% | 0.23 |
| Total Income | 1.11+382.6% | 0.23 |
| EXPENSES | ||
| Expenditure | 45.20+122.8% | 20.29 |
| Tax | 0.00 | 0.00 |
| PROFIT | ||
| PBT | -43.39-125.2% | -19.27 |
| Net Profit | -43.39-125.2% | -19.27 |
| KEY METRICS | ||
| OPM % | -100.00% | -100.00% |
| NPM % | -100.00% | -100.00% |
| EPS | -0.20-122.2% | -0.09 |
Corporate Events
Board MeetingTNYA
202613Jul
Board Meeting
CFO Appointment and SVP Finance Retirement — Eric Hyllengren…
SEC Filing ↗ Board MeetingTNYA
202627May
Board Meeting
Annual Meeting of Stockholders to elect Class II Directors, …
SEC Filing ↗